Regulatory Audit
Official government evaluations verify that manufacturing facilities comply with public health standards. Conducting FDA inspections ensures that pharmaceutical plants and food processors follow current good manufacturing practices. These assessments are scheduled on both a routine basis and in response to specific product quality reports.
Auditors examine everything from equipment cleanliness to digital record-keeping systems.
Inspection Protocol
On-site investigations utilize a structured methodology to review production processes and quality control records. During typical FDA inspections, investigators trace specific batches of product from raw material intake to final packaging. They interview plant personnel and take physical samples of products or ingredients for laboratory analysis.
The goal is to identify deviations from standard operating procedures that could compromise safety.
Compliance Consequence
Administrative actions follow the identification of critical non-compliance issues at a production facility. If FDA inspections reveal serious violations, the agency issues a formal warning letter outlining the required corrective actions. Companies must respond with a detailed remediation plan within a specified timeframe to avoid further legal penalties.
Failure to resolve these issues can lead to product seizures or manufacturing injunctions. This regulatory pressure forces manufacturers to maintain rigorous quality control systems at all times. This continuous readiness helps companies avoid the severe financial losses associated with forced plant shutdowns.